Government Affairs
Refine Search
Pharmaceutical
A new parliamentary committee is to work on a master plan to beat cancer. 18 June 2020
Generics
Even as China settles down post COVID-19, the Indian pharmaceutical industry is bracing itself for a reduction in profit margins in the short term, given the expected rise in the prices of active pharmaceutical ingredients (API) and key starting materials (KSM). Aiming to reduce import dependency and to attain self-reliance and drug security, the Indian government has decided to provide incentives to the pharmaceutical industry, reports The Pharma Letter’s India correspondent. 17 June 2020
Generics
India is set to impose anti-dumping duty on Chinese antibacterial drug ciprofloxacin hydrochloride in order to guard its domestic industry from cheap imports from the Asian neighbor. 17 June 2020
Pharmaceutical
Global drugmakers operating in Russia have called on the national government to lift the existing “third excess,” norm - the rule, limiting the participation of foreign drugmakers in state tenders in Russia. 16 June 2020
Pharmaceutical
In a move expected to shave approval time for clinical trials to three months from the current 12 months, the Indian government has designated the Central Drugs Standard Control Organization (CDSCO) as the first point of registration for clinical trials of all drugs and vaccines. 12 June 2020
Pharmaceutical
The share of Russian drugs in public procurements, which are carried out with the state program for high-cost nosologies program, which involves purchases of the most expensive drugs for the needs of Russian hospitals and other medical institutions – has reached a historic maximum of 42.7% and currently continues to grow, according to recent statements made by some local analysts and Russian media, reports The Pharma Letter’s local correspondent. 9 June 2020
Pharmaceutical
A total of 11 Russian pharmaceutical industry organizations uniting drug manufacturers, distributors, pharmacy organizations and the patient community wrote a collective letter addressed to Vladimir Putin, President of the Russian Federation, drawing his attention to the unwillingness to launch the industrial operation of the monitoring system drug movements and provide arguments why it is necessary to postpone the start, scheduled for July 1, 2020. 8 June 2020
Biotechnology
Of around 50 biopharma companies and contract manufacturing organizations that took advantage of a US government $659 billion loan program, five are working on COVID-19 therapies. 3 June 2020
Biotechnology
The US Department of Health and Human Services (HHS) has added $628 million to its contract with Emergent BioSolutions to advance manufacturing capabilities and capacity for a potential COVID-19 vaccine as well as therapeutics. 2 June 2020
Generics
Russia plans to create conditions for the development of its own production of active pharmaceutical ingredients (APIs) within the next several years, which will allow the country to resolve its dependence on supplies from India and China, that have significantly declined since the beginning of the COVID-19 pandemic. 27 May 2020
Biotechnology
Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new Pioneer Institute study finds that many companies will emerge from the pandemic commercially weaker, dealing with delays in new product launches and with fewer resources to invest in research and development. 21 May 2020
Biotechnology
Anglo-Swedish drugmaker AstraZeneca and the UK government are putting plenty behind their efforts to come up with a coronavirus vaccine. 19 May 2020
Pharmaceutical
The Information Technology and Innovation Foundation (ITIF), a Washington DC independent think tank focusing on science and technology policy , yesterday, at the 73rd World Health Assembly, joined a worldwide network of independent think tanks to issue a “Joint Declaration on the Importance of Collaboration, Open Trade, and Innovation in Tackling COVID-19,” calling on governments to take a specific series of measures related to trade and innovation in order to save lives and prepare countries for future pandemics and public health challenges. 19 May 2020
Biotechnology
Paris-based Sanofi has been forced to walk back claims that the USA would be entitled to the largest order of its investigational COVID-19 vaccine, should it be successfully developed. 15 May 2020
Generics
The Russian government plans to provide support to producers of cheap drugs, with the aim to prevent their disappearance from the domestic market, according to recent statements by representatives of some senior state officials and industry’s analysts, reports The Pharma Letter’s local correspondent. 12 May 2020
Generics
Generic drugmaker Apotex has admitted to fixing the price of a widely-used cholesterol drug and has accepted a $24.1 million fine from a US court. 11 May 2020
Pharmaceutical
A pledging conference led by the European Union (EU) has set an initial target of 7.5 billion euros ($8.1 billion) to help end the coronavirus pandemic. 5 May 2020
Biotechnology
There was a time when executives at Teva Pharmaceutical Industries thought that their product might be the third anti-calcitonin gene-related peptide (CGRP) drug to be recommended by the National Institute for Health and Care Excellence (NICE). 29 April 2020
Pharmaceutical
Canada has committed more than C$1 billion ($700 million) as part of a new national medical research strategy to fight COVID-19. 24 April 2020
Pharmaceutical
New research from the OECD highlights the scale of pharmaceutical and medical products counterfeiting - a global problem that has been exacerbated by the COVID-19 pandemic. 21 April 2020
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze